Pitt Innovators Deliver Robust Year of Impact in Fiscal 2026
Fiscal Year 2026 marked a year of remarkable progress across the University of Pittsburgh’s... Read more
SkinJect is a novel dissolvable microneedle patch being developed as a treatment for basal cell and squamous cell skin cancer.